The chymase mouse mast cell protease 4 degrades TNF, limits inflammation, and promotes survival in a model of sepsis
- PMID: 22901752
- PMCID: PMC3432424
- DOI: 10.1016/j.ajpath.2012.05.013
The chymase mouse mast cell protease 4 degrades TNF, limits inflammation, and promotes survival in a model of sepsis
Abstract
Mouse mast cell protease 4 (mMCP-4), the mouse counterpart of human mast cell chymase, is thought to have proinflammatory effects in innate or adaptive immune responses associated with mast cell activation. However, human chymase can degrade the proinflammatory cytokine TNF, a mediator that can be produced by mast cells and many other cell types. We found that mMCP-4 can reduce levels of mouse mast cell-derived TNF in vitro through degradation of transmembrane and soluble TNF. We assessed the effects of interactions between mMCP-4 and TNF in vivo by analyzing the features of a classic model of polymicrobial sepsis, cecal ligation and puncture (CLP), in C57BL/6J-mMCP-4-deficient mice versus C57BL/6J wild-type mice, and in C57BL/6J-Kit(W-sh/W-sh) mice containing adoptively transferred mast cells that were either wild type or lacked mMCP-4, TNF, or both mediators. The mMCP-4-deficient mice exhibited increased levels of intraperitoneal TNF, higher numbers of peritoneal neutrophils, and increased acute kidney injury after CLP, and also had significantly higher mortality after this procedure. Our findings support the conclusion that mMCP-4 can enhance survival after CLP at least in part by limiting detrimental effects of TNF, and suggest that mast cell chymase may represent an important negative regulator of TNF in vivo.
Copyright © 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.
Figures





Similar articles
-
Critical role of mast cell chymase in mouse abdominal aortic aneurysm formation.Circulation. 2009 Sep 15;120(11):973-82. doi: 10.1161/CIRCULATIONAHA.109.849679. Epub 2009 Aug 31. Circulation. 2009. PMID: 19720934 Free PMC article.
-
Mast cell chymase degrades the alarmins heat shock protein 70, biglycan, HMGB1, and interleukin-33 (IL-33) and limits danger-induced inflammation.J Biol Chem. 2014 Jan 3;289(1):237-50. doi: 10.1074/jbc.M112.435156. Epub 2013 Nov 20. J Biol Chem. 2014. PMID: 24257755 Free PMC article.
-
Mast cells protect from post-traumatic brain inflammation by the mast cell-specific chymase mouse mast cell protease-4.FASEB J. 2013 Mar;27(3):920-9. doi: 10.1096/fj.12-204800. Epub 2012 Nov 27. FASEB J. 2013. PMID: 23193170
-
Mast Cell Chymase and Kidney Disease.Int J Mol Sci. 2020 Dec 30;22(1):302. doi: 10.3390/ijms22010302. Int J Mol Sci. 2020. PMID: 33396702 Free PMC article. Review.
-
Mast cell tryptases and chymases in inflammation and host defense.Immunol Rev. 2007 Jun;217:141-54. doi: 10.1111/j.1600-065X.2007.00509.x. Immunol Rev. 2007. PMID: 17498057 Free PMC article. Review.
Cited by
-
Malaria-associated L-arginine deficiency induces mast cell-associated disruption to intestinal barrier defenses against nontyphoidal Salmonella bacteremia.Infect Immun. 2013 Oct;81(10):3515-26. doi: 10.1128/IAI.00380-13. Epub 2013 May 20. Infect Immun. 2013. PMID: 23690397 Free PMC article.
-
Immunological Considerations for the Development of an Effective Herpes Vaccine.Microorganisms. 2024 Sep 6;12(9):1846. doi: 10.3390/microorganisms12091846. Microorganisms. 2024. PMID: 39338520 Free PMC article. Review.
-
LPS Guides Distinct Patterns of Training and Tolerance in Mast Cells.Front Immunol. 2022 Feb 17;13:835348. doi: 10.3389/fimmu.2022.835348. eCollection 2022. Front Immunol. 2022. PMID: 35251027 Free PMC article.
-
Diverse exocytic pathways for mast cell mediators.Biochem Soc Trans. 2018 Apr 17;46(2):235-247. doi: 10.1042/BST20170450. Epub 2018 Feb 22. Biochem Soc Trans. 2018. PMID: 29472369 Free PMC article. Review.
-
Biomarkers and Their Possible Functions in the Intestinal Microenvironment of Chagasic Megacolon: An Overview of the (Neuro)inflammatory Process.J Immunol Res. 2021 Apr 7;2021:6668739. doi: 10.1155/2021/6668739. eCollection 2021. J Immunol Res. 2021. PMID: 33928170 Free PMC article. Review.
References
-
- Cohen J. The immunopathogenesis of sepsis. Nature. 2002;420:885–891. - PubMed
-
- Martin G.S., Mannino D.M., Eaton S., Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546–1554. - PubMed
-
- Patel G.P., Gurka D.P., Balk R.A. New treatment strategies for severe sepsis and septic shock. Curr Opin Crit Care. 2003;9:390–396. - PubMed
-
- Metz M., Grimbaldeston M.A., Nakae S., Piliponsky A.M., Tsai M., Galli S.J. Mast cells in the promotion and limitation of chronic inflammation. Immunol Rev. 2007;217:304–328. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous